Adv Sci (Weinh)

1. XIONG K, Chen S, Xu H, Tu S, et al
   RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer.
   Adv Sci (Weinh). 2025 Apr 3:e2408311. doi: 10.1002/advs.202408311.
   

   >> Share

   
   

   
   Aktuelle Urol

2. CLAUSER S, Palermo M, Palermo S, Comploj E, et al
   [An extremely rare case of multiple recurrences of urothelial carcinoma in an ileal neobladder: a case report and review of the literature].
   Aktuelle Urol. 2025;56:164-169.
   

   >> Share

   
   

   
   Arab J Urol

3. AL-QUDIMAT AR, Sabir D, Elamin M, Ching M, et al
   Implementing VIRADS score for image-guided assessment of muscle invasiveness in bladder cancer pre-TURBT: An updated meta-analysis.
   Arab J Urol. 2024;23:97-108.
   

   >> Share

   
   

   
   Asian Pac J Cancer Prev

4. RAMADHAN HH, Abdul-Rasheed OF, Alhamedi SAM, Mezban SG, et al
   Exploring The Prevalence of Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer Patients and Their Correlation with Tumor Characteristics.
   Asian Pac J Cancer Prev. 2025;26:1053-1058.
   

   >> Share

   
   
5. EL-ZOHERY NT, Shalaby YR, Kasem AI, Mostafa RR, et al
   CD 14 Expression in Urothelial Carcinoma of The Urinary Bladder (Histopathological and Immunohistochemical Study).
   Asian Pac J Cancer Prev. 2025;26:889-897.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. LU X, Shui KM, Ji H, Chen JY, et al
   Nerve infiltration of bladder cancer predicts response to immunotherapy.
   Biochem Biophys Res Commun. 2025;761:151687.
   

   >> Share

   
   

   
   Biochem Pharmacol

7. LI K, Li Y, Zhang Y, Lv J, et al
   N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer.
   Biochem Pharmacol. 2025;236:116903.
   

   >> Share

   
   

   
   BJUI Compass

8. LIM KY, Huynh TNA, Wei G, Kuriakose J, et al
   Intravesical gemcitabine and docetaxel vs. re-induction Bacillus Calmette Guerin as first-line salvage therapy for non-muscle invasive bladder cancer.
   BJUI Compass. 2025;6:e70012.
   

   >> Share

   
   

   
   Can Urol Assoc J

9. ISMAIL A, Kotb A
   Advocating female genital-sparing cystectomy as the standard of care for women with bladder cancer Re: "2025 Canadian Urological Association Guideline: Muscle-invasive bladder cancer" (Can Urol Assoc J 2025;19:E1-16).
   Can Urol Assoc J. 2025;19:E138-E139.
   

   >> Share

   
   

   
   Cancer Control

10. LAKKIS NA, Osman MH, Abdallah RM, Mokalled NM, et al
    Bladder Cancer in Lebanon: An Updated Epidemiological Comparison with Global Regions and a Comprehensive Review of Risk Factors.
    Cancer Control. 2025;32:10732748251330696.
    

    >> Share

    
    

    
    Cancer Immunol Res

11. GALSKY MD, Kockx M, Roels J, Van Elzen R, et al
    Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.
    Cancer Immunol Res. 2025;13:476-486.
    

    >> Share

    
    
12. KARUNAMURTHY A, Davar D
    There and back again: PD-L1 Positivity as a Biomarker for Immune Checkpoint Blockade in Urothelial Carcinoma.
    Cancer Immunol Res. 2025;13:454-455.
    

    >> Share

    
    

    
    Cancer Sci

13. 
    Correction to "Loss of Polarity Protein Par3, via Transcription Factor Snail, Promotes Bladder Cancer Metastasis".
    Cancer Sci. 2025 Apr 1. doi: 10.1111/cas.70073.
    

    >> Share

    
    

    
    Cell Death Dis

14. PENG D, Yang W, Tang T, He A, et al
    PLA2G7 promotes immune evasion of bladder cancer through the JAK-STAT-PDL1 axis.
    Cell Death Dis. 2025;16:234.
    

    >> Share

    
    

    
    Clin Genitourin Cancer

15. REZAEENIYA F, Hasandoost F, Abedi AR, Amanollahi A, et al
    Effectiveness of the Continuous Care Model on Quality of Life, Sexual Satisfaction and Function in Bladder Cancer Patients Undergoing Tumor Resection Surgery: A Randomized Control Trial.
    Clin Genitourin Cancer. 2025 Mar 4:102321. doi: 10.1016/j.clgc.2025.102321.
    

    >> Share

    
    

    
    Comput Biol Med

16. PARK S, Kang H, Choi Y, Yoon SG, et al
    Precision screening with sequential multi-algorithm reclassification technique (SMART): Saving bladders from unnecessary cystectomy.
    Comput Biol Med. 2025;189:109980.
    

    >> Share

    
    

    
    Curr Oncol Rep

17. MARTINEZ LM, Ribeiro LCSL, Guidi RG, de Moraes CMT, et al
    Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder.
    Curr Oncol Rep. 2025;27:225-235.
    

    >> Share

    
    

    
    Curr Opin Urol

18. RUDER S, Martinez J, Palmer J, Arham AB, et al
    Antibody-drug conjugates in urothelial carcinoma: current status and future.
    Curr Opin Urol. 2025;35:292-300.
    

    >> Share

    
    

    
    Discov Oncol

19. TABAEI S, Zareinejad M, Haghshenas MR, Shakhssalim N, et al
    Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics.
    Discov Oncol. 2025;16:436.
    

    >> Share

    
    
20. HE Y, Chen Y, Gao C
    A mendelian randomization study on the association between type 2 diabetes and the risk of bladder cancer.
    Discov Oncol. 2025;16:446.
    

    >> Share

    
    
21. YANG L, Zhang Z, Xu M, Shang M, et al
    Constructing a prognostic model based on MPT-related genes and investigate the characteristics of immune infiltration in bladder cancer.
    Discov Oncol. 2025;16:460.
    

    >> Share

    
    

    
    Eur J Nucl Med Mol Imaging

22. VAN GENNEP EJ, Pisano G, KleinJan GH, Rietbergen DDD, et al
    Prospective clinical study of sentinel node detection in bladder cancer using a hybrid tracer - Towards replacement of pelvic lymph node dissection in cases with sentinel node visualization on SPECT/CT?
    Eur J Nucl Med Mol Imaging. 2025 Apr 4. doi: 10.1007/s00259-025-07240.
    

    >> Share

    
    

    
    Expert Rev Anticancer Ther

23. MILLER EJ, Galsky MD
    An evaluation of nivolumab plus gemcitabine and cisplatin in the treatment of advanced urothelial carcinoma.
    Expert Rev Anticancer Ther. 2025;25:319-326.
    

    >> Share

    
    

    
    Explor Target Antitumor Ther

24. DI SPIRITO A, Balkhi S, Vivona V, Mortara L, et al
    Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies.
    Explor Target Antitumor Ther. 2025;6:1002304.
    

    >> Share

    
    

    
    FASEB J

25. LU BS, Liu KL, Yin YW, Zhang YP, et al
    A novel feedback regulation loop of METTL11A-MAFG-NPL4 promotes bladder cancer cell proliferation and tumor progression.
    FASEB J. 2025;39:e70466.
    

    >> Share

    
    

    
    Front Immunol

26. TORNIAI M, Martino GP, Gucciardino C, Angelici S, et al
    Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance.
    Front Immunol. 2025;16:1558964.
    

    >> Share

    
    
27. SZELES A, Kubik A, Vancsa S, Grunwald V, et al
    Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Front Immunol. 2025;16:1554048.
    

    >> Share

    
    

    
    Indian J Pathol Microbiol

28. FERNANDES G, Khumanthem G, Harinkhede N, Rojekar A, et al
    Primary signet ring cell adenocarcinoma arising in exstrophy of the urinary bladder (epispadias-exstrophy complex).
    Indian J Pathol Microbiol. 2025;68:165-167.
    

    >> Share

    
    

    
    J Appl Clin Med Phys

29. ZHANG Z, Liu CW, Donaghue JD, Murray EJ, et al
    Patient-specific adaptive planning margin for whole bladder radiation therapy.
    J Appl Clin Med Phys. 2025;26:e14617.
    

    >> Share

    
    

    
    Life Sci

30. DONG S, Wang L, Liu X, Hou D, et al
    CELF2 inhibits bladder cancer progression by decreasing the stability of CXCL5.
    Life Sci. 2025;370:123585.
    

    >> Share

    
    

    
    Macromol Biosci

31. HUANG Y, Li Z, Qiu H, Shen C, et al
    Drug-Loaded Mitochondrial Targeted Nanoparticles for Tumor Imaging and PDT/PTT Combined Chemotherapy in Muscle-Invasive Bladder Cancer.
    Macromol Biosci. 2025 Mar 31:e2400575. doi: 10.1002/mabi.202400575.
    

    >> Share

    
    

    
    Minerva Urol Nephrol

32. ARTILES MEDINA A, Subiela JD, Tagalos Munoz A, Tato Diez M, et al
    Clinical outcomes of BCG infections in patients undergoing intravesical immunotherapy for non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Minerva Urol Nephrol. 2025;77:13-24.
    

    >> Share

    
    

    
    Open Med (Wars)

33. LIU J, Zhou W, Zhang W, Chang C, et al
    The safety and efficacy of BCG combined with mitomycin C compared with BCG monotherapy in patients with non-muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Open Med (Wars). 2025;20:20241134.
    

    >> Share

    
    

    
    PeerJ

34. SONG J, Qiao J, Chen M, Li J, et al
    Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKT-mTOR pathway.
    PeerJ. 2025;13:e19085.
    

    >> Share

    
    

    
    Sci Rep

35. QIU Y, Wang Y, Liu J, Liu B, et al
    Single-cell sequencing uncovers a high ESM1-expression endothelial cell subpopulation associated with bladder cancer progression and the immunosuppressive microenvironment.
    Sci Rep. 2025;15:10946.
    

    >> Share

    
    
36. IBRAHIM TS, Saraya MS, Saleh AI, Rabie AH, et al
    An efficient graph attention framework enhances bladder cancer prediction.
    Sci Rep. 2025;15:11127.
    

    >> Share

    
    

    
    Tob Induc Dis

37. QI K, Cheng H, Jiang Y, Zheng Y, et al
    Contribution of smoking to the global burden of bladder cancer from 1990 to 2021 and projections to 2046.
    Tob Induc Dis. 2025;23:10.
    

    >> Share

    
    

    
    Urol Int

38. ELSAEED K, Moustafa H, Abdelghani S, ElAwady H, et al
    Anti-Reflux Ureteroileal Anastomosis for Orthotopic Ileal Neobladder Using Wallace Technique in a Single Trough.
    Urol Int. 2025;109:182-188.
    

    >> Share

    
    

    
    Urol Oncol

39. ERAKY A, Kolanukuduru KP, Hug B, Ben-David R, et al
    Differential response of low- and high-grade intermediate-risk non-muscle-invasive bladder cancer to bacillus Calmette-Guerin and gemcitabine-docetaxel therapy.
    Urol Oncol. 2025 Mar 31:S1078-1439(25)00105.
    

    >> Share

    
    

    
    Urologia

40. PAUDYAL P, Mete U, Gorsi U, Kumar S, et al
    Usefulness of multiparametric MRI for local staging of bladder cancer.
    Urologia. 2025;92:231-236.
    

    >> Share

    
    
41. BIZZARRI FP, Campetella M, Russo P, Marino F, et al
    Risk factors for benign uretero-enteric anastomotic strictures after open radical cystectomy and ileal conduit.
    Urologia. 2025;92:224-230.
    

    >> Share

    
    

    
    World J Urol

42. NEGRIER S, Bonastre J, Colrat F, Teitsson S, et al
    Cost-effectiveness of nivolumab compared with surveillance for adjuvant treatment of muscle-invasive urothelial carcinoma at high risk of recurrence in France.
    World J Urol. 2025;43:202.
    

    >> Share

    
    
43. MANGOLD MH, Nientiedt M, Waldbillig F, Michel MS, et al
    Optimizing treatment selection: outcomes of radical cystectomy in patients eligible for trimodal therapy.
    World J Urol. 2025;43:196.
    

    >> Share

    
    
44. LI J, Chong TW, Fong KY, Han BLJ, et al
    Will artificial intelligence (AI) replace cytopathologists: a scoping review of current applications and evidence of A.I. in urine cytology.
    World J Urol. 2025;43:200.
    

    >> Share

    
    
45. AFFERI L, Jahn B, Kelkar AH, Dijk SW, et al
    Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis.
    World J Urol. 2025;43:197.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share